JP2007518424A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518424A5
JP2007518424A5 JP2006551422A JP2006551422A JP2007518424A5 JP 2007518424 A5 JP2007518424 A5 JP 2007518424A5 JP 2006551422 A JP2006551422 A JP 2006551422A JP 2006551422 A JP2006551422 A JP 2006551422A JP 2007518424 A5 JP2007518424 A5 JP 2007518424A5
Authority
JP
Japan
Prior art keywords
nucleotide
buffer
nucleotide triphosphate
replacing
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006551422A
Other languages
English (en)
Japanese (ja)
Other versions
JP4866248B2 (ja
JP2007518424A6 (ja
JP2007518424A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002414 external-priority patent/WO2005070027A2/en
Publication of JP2007518424A publication Critical patent/JP2007518424A/ja
Publication of JP2007518424A6 publication Critical patent/JP2007518424A6/ja
Publication of JP2007518424A5 publication Critical patent/JP2007518424A5/ja
Application granted granted Critical
Publication of JP4866248B2 publication Critical patent/JP4866248B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006551422A 2004-01-23 2005-01-21 核酸増幅性能改良のための新規ヌクレオチド混合物 Expired - Fee Related JP4866248B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US53881604P 2004-01-23 2004-01-23
US53881504P 2004-01-23 2004-01-23
US53881404P 2004-01-23 2004-01-23
US60/538,814 2004-01-23
US60/538,816 2004-01-23
US60/538,815 2004-01-23
PCT/US2005/002414 WO2005070027A2 (en) 2004-01-23 2005-01-21 A novel nucleotide mixture for improved nucleic acid amplification performance

Publications (4)

Publication Number Publication Date
JP2007518424A JP2007518424A (ja) 2007-07-12
JP2007518424A6 JP2007518424A6 (ja) 2007-10-11
JP2007518424A5 true JP2007518424A5 (cg-RX-API-DMAC7.html) 2008-03-06
JP4866248B2 JP4866248B2 (ja) 2012-02-01

Family

ID=34812082

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006551423A Pending JP2007518425A (ja) 2004-01-23 2005-01-21 Ｈｃｖ３’非翻訳領域を効率的に増幅および検出するためのプライマーおよびプローブの設計
JP2006551422A Expired - Fee Related JP4866248B2 (ja) 2004-01-23 2005-01-21 核酸増幅性能改良のための新規ヌクレオチド混合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006551423A Pending JP2007518425A (ja) 2004-01-23 2005-01-21 Ｈｃｖ３’非翻訳領域を効率的に増幅および検出するためのプライマーおよびプローブの設計

Country Status (6)

Country Link
US (3) US7364854B2 (cg-RX-API-DMAC7.html)
EP (3) EP1706512B1 (cg-RX-API-DMAC7.html)
JP (2) JP2007518425A (cg-RX-API-DMAC7.html)
AT (3) ATE491810T1 (cg-RX-API-DMAC7.html)
DE (3) DE602005023586D1 (cg-RX-API-DMAC7.html)
WO (2) WO2005070027A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008134374A1 (en) * 2007-04-27 2008-11-06 Eragen Biosciences, Inc. Materials and methods for detection of hepatitis c virus
JP2009284896A (ja) 2007-07-26 2009-12-10 Fujifilm Corp 核酸増幅方法
US20090162856A1 (en) * 2007-11-06 2009-06-25 Hayato Miyoshi Rna detection method
AU2009335156A1 (en) * 2008-12-31 2010-07-08 Abbott Laboratories Primers and probes for detecting Hepatitis C virus

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (ja) * 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk Ｃ型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法
EP0052296B1 (en) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
DE3689223T2 (de) 1985-05-15 1994-03-03 Amoco Corp Cytidinanaloga.
US4876187A (en) 1985-12-05 1989-10-24 Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
EP0578329B1 (en) 1989-09-18 1996-03-13 Canon Kabushiki Kaisha Ink jet recording head and ink jet apparatus having same
CA2075050C (en) * 1990-02-16 1998-10-06 Will Bloch Specificity and convenience of the polymerase chain reaction
WO1993022461A1 (en) 1992-05-06 1993-11-11 Gen-Probe Incorporated Nucleic acid sequence amplification method, composition and kit
US5648232A (en) * 1993-01-21 1997-07-15 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological best method and reagents
JP3062250B2 (ja) * 1994-03-10 2000-07-10 ジェン−プローブ・インコーポレイテッド イオン性界面活性剤による、酵素により媒介される反応に対する阻害の抑制方法
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
DE19612779A1 (de) * 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Verfahren zur spezifischen Vervielfältigung von langen Nukleinsäuren durch PCR
WO1998006736A1 (en) * 1996-08-14 1998-02-19 Life Technologies, Inc. Stable compositions for nucleic acid amplification and sequencing
DE19647055A1 (de) * 1996-11-14 1998-05-20 Boehringer Mannheim Gmbh Stabilisierte wässrige Nukleosidtriphosphat-Lösungen
EP1705253B1 (en) * 1997-04-03 2010-11-03 Life Technologies Corporation Compositons and methods for reverse transcriptase-Polymerase chain reaction (RT-PCR)
ZA989950B (en) 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
KR20010043111A (ko) * 1998-04-27 2001-05-25 랄프 이. 크리스토퍼슨 Ｃ형 간염 바이러스성 감염과 관련된 질환의 효소적 핵산치료제
WO2000000638A2 (en) 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
US6300075B1 (en) 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US6638714B1 (en) 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
WO2000075338A2 (en) * 1999-06-04 2000-12-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
US6271004B1 (en) * 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
CA2392218A1 (en) * 1999-11-17 2001-05-25 Jiuping Ji Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay
WO2001064959A1 (en) 2000-03-02 2001-09-07 Akzo Nobel N.V. Detection of hepatitis b virus rna
CA2442092A1 (en) * 2001-03-26 2002-10-17 Ribozyme Pharmaceuticals, Inc. Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
WO2003016572A1 (en) * 2001-08-17 2003-02-27 Eli Lilly And Company Oligonucleotide therapeutics for treating hepatitis c virus infections
US6783940B2 (en) * 2001-10-31 2004-08-31 Applera Corporation Method of reducing non-specific amplification in PCR
US6750009B2 (en) 2002-01-29 2004-06-15 Apath, Llc Multiple viral replicon culture systems
WO2003100014A2 (en) 2002-05-24 2003-12-04 Smithkline Beecham Corporation Method for quantitating negative strand rna synthesis

Similar Documents

Publication Publication Date Title
JP2008245635A5 (cg-RX-API-DMAC7.html)
GT200500053S (es) Botella
MEP44608A (en) Methods for treating infectious disease exacerbated asthma
SG10201408300PA (en) Processing of amplified dna fragments for sequencing
TWI319718B (en) Hydrogen-producing fuel processing assemblies, heating assemblies, and methods of operating the same
BRPI0714876A2 (pt) glucanases, ácidos nucleicos codificando as mesmas e métodos para fabricar e usar as mesmas.
PT1935331E (pt) Processo para a preparação de elétrodos modificados, elétrodos preparados pelo referido processo e biossensores enzimáticos compreendendo os referidos elétrodos
EP1899800A4 (en) ETL DIAGRAM AND TOOL FOR STRUCTURED AND UNSTRUCTURED DATA
DK2035398T3 (da) Immobiliseret 1,2-benzisothioazolin-3-on
WO2006135684A3 (en) Methods and kits for sense rna synthesis
EP2071025A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE UGT1A1 GENE, REAGENT FOR THE REINFORCEMENT OF THE UGT1A1 GENE THEREFOR AND APPLICATION THEREOF
PL1937834T3 (pl) Sposoby wzmacniania, kwantyfikacji i identyfikacji kwasów nukleinowych
JP2009504138A5 (cg-RX-API-DMAC7.html)
EA200701742A1 (ru) Способы получения сиропа
EP2055789A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE CYP2C19 GENE, REAGENT FOR THE REINFORCEMENT OF THE CYP2C19 GENE THEREFOR AND APPLICATION THEREOF
JP2009520748A5 (cg-RX-API-DMAC7.html)
EP2116598A4 (en) Novel Beta GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE, GENE FOR THEIR CODING AND METHOD FOR INCREASING ENZYMATIC ACTIVITY
EP2055775A4 (en) PRIMER ASSEMBLY FOR AMPLIFYING THE CYP2C9 GENE, A REAGENT FOR CYP2C9 GENE AMPLIFICATION, AND USE THEREOF
JP2008542528A5 (cg-RX-API-DMAC7.html)
EP2029723A4 (en) TFLA-GEN, which may lead to the degradation of toxoflavin and its chemical derivatives, as well as the transgene-expressing transgenic organism
EP2055774A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE SULT1A1 GENE, REAGENT FOR THE REINFORCEMENT OF THE SULT1A1 GENIUS THEREFOR AND APPLICATIONS THEREOF
GB2450454A (en) Terminating substrates for DNA polymerases
EP1999068A4 (en) BIOGEL REVERSIBLE FOR THE HANDLING AND SEPARATION OF CARBON NANOTUBES IN A WALL
JP2007530049A5 (cg-RX-API-DMAC7.html)
EP2078747A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE NAT2 GENE, REAGENT FOR THE REINFORCEMENT OF THE NAT2 GENE THEREFOR AND APPLICATION THEREOF